AFT Pharmaceuticals (AFT Pharmaceuticals) EBIT per Share : $0.15 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals EBIT per Share?

AFT Pharmaceuticals's EBIT per Share for the three months ended in Mar. 2024 was $0.13. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.15.

During the past 12 months, the average EBIT per Share Growth Rate of AFT Pharmaceuticals was 22.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 31.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 32.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for AFT Pharmaceuticals's EBIT per Share or its related term are showing as below:

AFTPF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 15.8 Med: 31.8 Max: 61.8
Current: 31.8

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of AFT Pharmaceuticals was 61.80% per year. The lowest was 15.80% per year. And the median was 31.80% per year.

AFTPF's 3-Year EBIT Growth Rate is ranked better than
78.49% of 860 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs AFTPF: 31.80

AFT Pharmaceuticals's EBIT for the three months ended in Mar. 2024 was $13.34 Mil.

AFT Pharmaceuticals EBIT per Share Historical Data

The historical data trend for AFT Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals EBIT per Share Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

0.13

0.08

0.14

0.11

0.15

AFT Pharmaceuticals Quarterly Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT per Share	Get a 7-Day Free Trial												0.10	0.02	0.09	0.02	0.13

AFT Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

AFT Pharmaceuticals's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	15.636	/	104.849
=	0.15

AFT Pharmaceuticals's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	13.335	/	104.849
=	0.13

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15

AFT Pharmaceuticals (OTCPK:AFTPF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

AFT Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand AFP:Australia

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.